Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

Delayed Quote. Delayed  - 05/25 05:35:16 pm
45 GBp   --.--%
05/19 VERNALIS : Moxatag Supply Update
05/19 VERNALIS : Says Supplier Of Moxatag Placed In Provisional Liquidatio..
04/26 VERNALIS : Posting of Circular and Notice of General Meeting
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
05/19/2016 05/20/2016 05/23/2016 05/24/2016 05/25/2016 Date
43(c) 46(c) 44.875(c) 45(c) 45(c) Last
777 190 3 067 985 2 181 566 30 835 186 906 Volume
-12.02% +6.98% -2.45% +0.28% 0.00% Change
More quotes
Financials ( GBP)
Sales 2016 11,6 M
EBIT 2016 -30,0 M
Net income 2016 -24,3 M
Finance 2016 19,0 M
Yield 2016 -
Sales 2017 19,7 M
EBIT 2017 -25,0 M
Net income 2017 -22,7 M
Finance 2017 8,89 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 18,7x
EV / Sales 2017 11,5x
Capitalization 236 M
More Financials
Company
Vernalis Plc engages in the research, development, and commercialization of pharmaceutical products under the Tuzistra XR brand.The company was founded by Keith G. McCullagh in 1986 and is headquartered in Winnersh, United Kingdom. 
More about the company
Surperformance© ratings of Vernalis plc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERNALIS PLC
05/19 VERNALIS : Moxatag Supply Update
05/19 VERNALIS : Says Supplier Of Moxatag Placed In Provisional Liquidation
04/26 VERNALIS : Posting of Circular and Notice of General Meeting
04/26 UPDATE : Backed By CEO And Investors, Vernalis Raises GBP40 Million (ALLISS)
04/26 VERNALIS : Eyes US Cough Cold Market With GBP40 Million Fundraising (ALLISS)
04/21 VERNALIS : Appoints Sandford Sommer as President & Chief Operating Officer, Vern..
04/21 VERNALIS : Sandford Sommer appointed as President & COO in US
04/21 VERNALIS : Taps AstraZeneca Veteran Sommer For US Business
More news
Sector news : Biotechnology & Medical Research - NEC
08:49aDJSANOFI : Moves to Replace Medivation's Board -- WSJ
06:16aDJREGENERON PHARMACEUTICALS : Named as Science Talent Search Sponsor
01:10a AMGEN : Announces Early Tender Results Of Senior Notes Exchange Offers
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
03/17 Vernalis ADR reports 6M'15 results
2015 Vernalis acquires U.S. rights to extended-release antibiotic


Comments 
Advertisement
Chart VERNALIS PLC
Duration : Period :
Vernalis plc Technical Analysis Chart | VER | GB00B3Y5L754 | 4-Traders
Full-screen chart
Technical analysis trends VERNALIS PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions